Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sachdev Amit
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   71,325    

Indirect Shares

   7,447      
Direct Value   $26,276,609    

Indirect Value

   $3,536,953      
Total Shares   78,772      
Total Value   $29,813,561      


Vertex Pharmaceuticals Inc $26,276,609 Celladon Corp $0 Vertex Pharmaceuticals Inc $26,276,609 Celladon Corp $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP Chief Patient & Ex... 2024-05-15 55,325 2024-05-15 7,447    Premium*  
            Celladon Corp CLDN 2022-03-11 16,000 2020-03-12 0    Premium*  
* Premium Members only  

Records found :    193         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2023-02-13 4 D $298.26 $1,388,997 D/D (4,657) 72,484 0 -
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-06 4 A $0.00 $0 D/D 13,680 72,494 0 -
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-12 4 AS $420.24 $1,354,013 D/D (3,222) 74,364 0 %
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2019-02-06 4 A $0.00 $0 D/D 37,223 75,260 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2023-02-10 4 D $294.33 $768,496 D/D (2,611) 77,141 0 -
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-09 4 D $422.74 $854,780 D/D (2,022) 77,586 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2014-10-30 4 A $0.01 $400 D/D 40,000 78,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2014-11-17 4 AS $111.97 $15,004 D/D (134) 78,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2014-11-28 4 AS $120.00 $1,440,000 D/D (12,000) 78,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-01-09 4 AS $125.00 $1,500,000 D/D (12,000) 78,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-04 4 OE $86.52 $4,942,968 D/D 43,752 78,855 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-10-30 4 AS $123.34 $745,433 D/D (5,938) 78,963 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-11-16 4 AS $122.28 $10,394 D/D (85) 78,963 0 -
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-07 4 A $0.00 $0 D/D 7,114 79,608 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2023-02-01 4 A $0.00 $0 D/D 26,400 79,752 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2014-06-24 4 OE $33.28 $1,420,998 D/D 42,250 80,921 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-03-23 4 AS $122.78 $638,756 D/D (5,083) 84,901 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-05-15 4 AS $123.85 $16,224 D/D (131) 84,901 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2016-02-03 4 AS $89.91 $923,460 D/D (10,166) 86,096 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2016-05-16 4 AS $81.67 $9,555 D/D (117) 86,096 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2016-11-15 4 AS $93.36 $10,830 D/D (116) 86,096 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-05-07 4 OE $29.25 $1,645,313 D/D 56,250 89,858 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-02-18 4 AS $112.62 $670,256 D/D (5,937) 89,984 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-03-18 4 AS $130.00 $1,560,000 D/D (12,000) 89,984 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-03-20 4 AS $135.08 $1,620,960 D/D (12,000) 89,984 0 -
  193  Records found
  1   2   3   4   5   6   7  8      
  Page 7 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us